Zobrazeno 1 - 10
of 344
pro vyhledávání: '"β3-adrenergic receptor"'
Autor:
Haifeng Song, Lei Liang, Hui Liu, Yubao Liu, Weiguo Hu, Gang Zhang, Bo Xiao, Meng Fu, Jianxing Li
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
ObjectiveTo systematically review and quantitively evaluate the efficacy and safety of mirabegron as a medical expulsive therapy for ureteral stones.MethodsWe performed an extensive search of the EMBASE and PubMed databases for studies examining the
Externí odkaz:
https://doaj.org/article/98ebad12584240e8a7d31bdbf348fc80
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yi Zhu, Na Li, Mingyang Huang, Xi Chen, Yu A. An, Jianping Li, Shangang Zhao, Jan-Bernd Funcke, Jianhong Cao, Zhenyan He, Qingzhang Zhu, Zhuzhen Zhang, Zhao V. Wang, Lin Xu, Kevin W. Williams, Chien Li, Kevin Grove, Philipp E. Scherer
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 7, Pp 3063-3072 (2022)
Adipose tissue is a promising target for treating obesity and metabolic diseases. However, pharmacological agents usually fail to effectively engage adipocytes due to their extraordinarily large size and insufficient vascularization, especially in ob
Externí odkaz:
https://doaj.org/article/9f7116cbe4124a1d906ae08cbc4f4d5c
Autor:
Xin‐Yuan Zhao, Ying Liu, Xuan Zhang, Ben‐Chi Zhao, George Burley, Zhi‐Can Yang, Yi Luo, An‐Qi Li, Ruo‐Xin Zhang, Zhi‐Ying Liu, Yan‐Chuan Shi, Qiao‐Ping Wang
Publikováno v:
MedComm, Vol 4, Iss 2, Pp n/a-n/a (2023)
Abstract Anti‐obesity medications act by suppressing energy intake (EI), promoting energy expenditure (EE), or both. Metformin (Met) and mirabegron (Mir) cause weight loss by targeting EI and EE, respectively. However, anti‐obesity effects during
Externí odkaz:
https://doaj.org/article/e98806f50d984fd699939b3df1646c3f
Autor:
Akinori Hara, Phat Minh Nguyen, Hiromasa Tsujiguchi, Masaharu Nakamura, Yohei Yamada, Keita Suzuki, Fumihiko Suzuki, Tomoko Kasahara, Oanh Kim Pham, Haruki Nakamura, Yasuhiro Kambayashi, Yukari Shimizu, Thao Thi Thu Nguyen, Sakae Miyagi, Takayuki Kannon, Takehiro Sato, Kazuyoshi Hosomichi, Atsushi Tajima, Hiroyuki Nakamura
Publikováno v:
Obesity Science & Practice, Vol 8, Iss 2, Pp 199-207 (2022)
Abstract Objectives The β3‐adrenergic receptor (ADRB3) gene polymorphism has been implicated in obesity. Therefore, the contribution of ADRB3 Trp64Arg polymorphism to obesity‐related indicators was investigated, taking into account the lifestyle
Externí odkaz:
https://doaj.org/article/a057ae4cc00b4695a9855a600c7674aa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 121-126 (2021)
World studies have shown that the mean prevalence of overactive bladder (OAB) ranges today from 11 to 16% of the global population and is common in both men and women. In addition, OAB is a diagnosis by exclusion. The article discusses two large grou
Externí odkaz:
https://doaj.org/article/f34a47c44b1441be8375e5f31b3ff0cc
Autor:
Mario D’Ambrosio, Elisabetta Bigagli, Lorenzo Cinci, Manuela Gencarelli, Sofia Chioccioli, Natascia Biondi, Liliana Rodolfi, Alberto Niccolai, Francesca Zambelli, Annunziatina Laurino, Laura Raimondi, Mario R. Tredici, Cristina Luceri
Publikováno v:
Marine Drugs, Vol 21, Iss 5, p 303 (2023)
Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine microalga Tisochrysis lutea F&M-M36 (T. lut
Externí odkaz:
https://doaj.org/article/2b63d0268dd7459c84872980985d7a25
Autor:
Ziwen Wang, Shanshan Li, Ruifeng Wang, Liansheng Guo, Dan Xu, Tieyuan Zhang, Yifan Xu, Wenlong Wang, Min Wang, Zhongwei Gan, Xiaobing Wang
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-14 (2020)
Abstract Background Our objective was to investigate the efficacy of the beta-3 adrenergic receptor (β3-AR) agonist BRL37344 for the prevention of liver steatosis and inflammation associated with nonalcoholic fatty liver disease (NAFLD). Methods Fou
Externí odkaz:
https://doaj.org/article/31bb61fc1f184e05ad3419dfa1a44b03